Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-04-13

FDA Approved: ROPINIROLE HYDROCHLORIDE — Supplemental Application (SOLCO HEALTHCARE US, LLC)

View source ↗

Summary

The FDA approved a supplemental Abbreviated New Drug Application to authorize a generic ropinirole hydrochloride product from Solco Healthcare US, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ropinirole hydrochloride (ropinirole hydrochloride)

Snippet

SUPPL AP for ROPINIROLE HYDROCHLORIDE (ROPINIROLE HYDROCHLORIDE)